Financials

  • Market Capitalization 1.72 B
  • Employee 167
  • Founded 2019
  • CEO N/A
  • Website www.zenasbio.com
  • Headquarter Delaware, United States
  • FIGI BBG01J1MG9D6
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.3
Rapporto prezzo/fatturato
162.41

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2037
NTLA
Intellia Therapeutics, Inc. - Common Stock
12.58 USD-3.75%+0.64%+7.89%-8.31%1.76 B USD
2039
SEPN
Septerna, Inc. - Common Stock
37.56 USD-2.11%-1.08%-2.85%+70.65%1.75 B USD
2049
NUVB
Nuvation Bio Inc. Class A Common Stock
4.90 USD-2.00%-1.01%-16.95%+34.25%1.72 B USD
2060
GPCR
Structure Therapeutics Inc - American Depositary Shares
23.91 USD-6.38%-13.21%-38.57%-10.58%1.71 B USD